Rearrangement-enhancing element upstream of the mouse immunoglobulin kappa chain J cluster

Science

Volumn 271, Issue 5254, 1996, Pages 1416-1420

  Ferradini, Laurent ^a   Gu, Hua ^b,c   De Smet, Annie ^a   Rajewsky, Klaus ^b   Reynaud, Claude Agnès ^a   Weill, Jean Claude ^a  

^a INSERM   (France)

^b UNIVERSITY OF COLOGNE   (Germany)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; GENE CLUSTER; GENE MUTATION; GENE REARRANGEMENT; IMMUNOGLOBULIN GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0029983577     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.271.5254.1416     Document Type: Article

References (47)

1. G D Yancopoulos and F. W. Alt, Cell 40, 271 (1985).
2. F. W Alt, N. Rosenberg, S. Lewis, E. Thomas, D. Baltimore, ibid 27, 381 (1981)
3. G D. Yancopoulos, T. K Blaokwell, H. Suh, L. Hood, F. W. Alt, ibid. 44, 251 (1986), D. G Schatz, M. A. Oettinger, D. Baltimore, ibid. 59, 1035 (1989); M. A. Oettinger, D. G. Schatz, C Gorka, D. Baltimore, Science 248, 1517 (1990).
4. G D. Yancopoulos, T. K Blaokwell, H. Suh, L. Hood, F. W. Alt, ibid. 44, 251 (1986), D. G Schatz, M. A. Oettinger, D. Baltimore, ibid. 59, 1035 (1989); M. A. Oettinger, D. G. Schatz, C Gorka, D. Baltimore, Science 248, 1517 (1990).
5. G D. Yancopoulos, T. K Blaokwell, H. Suh, L. Hood, F. W. Alt, ibid. 44, 251 (1986), D. G Schatz, M. A. Oettinger, D. Baltimore, ibid. 59, 1035 (1989); M. A. Oettinger, D. G. Schatz, C Gorka, D. Baltimore, Science 248, 1517 (1990).
6. P. Femer et al , EMBO J 9, 117 (1990), S. Takeda et al , ibid. 12, 2329 (1993).
7. P. Femer et al , EMBO J 9, 117 (1990), S. Takeda et al , ibid. 12, 2329 (1993).
8. M Serwe and F. Sablitzky, ibid. 12, 2321 (1993); J Chen et al , ibid., p. 4635.
9. M Serwe and F. Sablitzky, ibid. 12, 2321 (1993); J Chen et al , ibid., p. 4635.
10. R Lauster et al., ibid., p. 4615.
11. D. Buccrhini et al., Nature 326, 409 (1987)
12. L. Ferradini, C.-A. Reynaud, R Lauster, J.-C Weill, Semin Immunol 6, 165 (1994)
13. D Weaver and D. Baltimore, Proc. Natl. Acad Sci. U S.A 84, 1516 (1987).
14. M. R. Capecchi, Science 244, 1288 (1989)
15. K locus was provided by B. Van Ness (24).
16. N. Sternberg and D. Hamilton, J. Mol. Biol. 150, 467 (1981); B. Sauer and N. Henderson, New Biol 2, 441 (1990)
17. N. Sternberg and D. Hamilton, J. Mol. Biol. 150, 467 (1981); B. Sauer and N. Henderson, New Biol 2, 441 (1990)
18. H. Gu, Y.-R Zou, K. Rajewsky, Cell 73, 1155 (1993).
19. K1 The HSV-tk gene was obtained from the plC19R plasmid (15) and ligated blunt-ended as a Cla l - Hind III fragment into the Sal I site of the pSPIg8 plasmid. The targeted vector was then linearized with Bam HI for transfection.
20. S. L Mansour, K. R Thomas, M R Capecchi, Nature 336, 348 (1988).
21. r gene deletion by Southem blot analysis
22. R. Kühn, K Rajewsky, W. Muller, Science 254, 707 (1991)
23. L Ferradini et al., data not shown.
24. C. Deng, K R. Thomas, M. R. Capecchi, Mol. Cell Biol 13, 2134 (1993).
25. +) from 2-week-old mutant and wifd-type mice.
26. +) corresponding to immature and mature B cells, respectively, were also represented in mutant mice. Similar results were obtained by analyzing bone marrow cells from 2-week-old mutant mice.
27. D. L Wood and C Coleclough, Proc. Natl. Acad. Sci. U.S.A. 81, 4756 (1984); M. Nishi, T. Kataaka, T. Honjo, ibid. 82, 6399 (1985); C. A Medina and J M. Teale, J. Exp Med. 177, 1317 (1993).
28. D. L Wood and C Coleclough, Proc. Natl. Acad. Sci. U.S.A. 81, 4756 (1984); M. Nishi, T. Kataaka, T. Honjo, ibid. 82, 6399 (1985); C. A Medina and J M. Teale, J. Exp Med. 177, 1317 (1993).
29. D. L Wood and C Coleclough, Proc. Natl. Acad. Sci. U.S.A. 81, 4756 (1984); M. Nishi, T. Kataaka, T. Honjo, ibid. 82, 6399 (1985); C. A Medina and J M. Teale, J. Exp Med. 177, 1317 (1993).
30. T. K. Blackwell et al. Nature 324, 585 (1986); F W. Alt, T. K Blackwell, G. D. Yancopoulos, Science 238, 1079 (1987); M. S. Schlissel and D. Baltimore, Cell 158, 1001 (1989)
31. T. K. Blackwell et al. Nature 324, 585 (1986); F W. Alt, T. K Blackwell, G. D. Yancopoulos, Science 238, 1079 (1987); M. S. Schlissel and D. Baltimore, Cell 158, 1001 (1989)
32. T. K. Blackwell et al. Nature 324, 585 (1986); F W. Alt, T. K Blackwell, G. D. Yancopoulos, Science 238, 1079 (1987); M. S. Schlissel and D. Baltimore, Cell 158, 1001 (1989)
33. B G Van Ness Cell 27, 593 (1981).
34. L. Leclerc, P. Butkeraitis, M. Reth, Nucleic Acid Res 17, 6809 (1989); D. J. Martin and B G Van Ness, Mol Cell. Biol 10, 1950 (1990).
35. L. Leclerc, P. Butkeraitis, M. Reth, Nucleic Acid Res 17, 6809 (1989); D. J. Martin and B G Van Ness, Mol Cell. Biol 10, 1950 (1990).
36. The methylation status of the Hha I site located just upstream of the KI and KII sites [U Storb and B. Arp, Proc Natl. Acad. Sci. U.S.A 80, 6642 (1983), K. J. Nelson, E L. Mather, R. P. Perry, Nucleic Acids Res. 12, 1911 (1984)] was studied with the same PCR assay as the one described in Fig. 3. Bone marrow fractions C′ and D, representing the cell populations engaged in the process of κ light chain rearrangement, were sorted from heterozygous animals (2) and the proportion of each allele assessed before and after Hha I (methylation-sensitive) digestion. No obvious difference in methylation between the wild-type and the mutant allele was observable in this assay (18).
37. The methylation status of the Hha I site located just upstream of the KI and KII sites [U Storb and B. Arp, Proc Natl. Acad. Sci. U.S.A 80, 6642 (1983), K. J. Nelson, E L. Mather, R. P. Perry, Nucleic Acids Res. 12, 1911 (1984)] was studied with the same PCR assay as the one described in Fig. 3. Bone marrow fractions C′ and D, representing the cell populations engaged in the process of κ light chain rearrangement, were sorted from heterozygous animals (2) and the proportion of each allele assessed before and after Hha I (methylation-sensitive) digestion. No obvious difference in methylation between the wild-type and the mutant allele was observable in this assay (18).
38. These results differ from those obtained by Takeda et al (4) with the intronic κ enhancer knock-out; in mice homozygous for that mutation, κ rearrangement is completely blocked The total number of B cells in these mice was about half that in normal mice, and only λ-expressing B cells were detected in the periphery. Whether the deletion of the intronic κ enhancer is sufficient by itself to completely abolish accessibility and rearrangement remains an open question. The neomycin gene left in the κ locus at the site of the enhancer might by itself contribute to making the block of rearrangement observed in Takeda et al complete (4) The sole insertion of the neomycin gene at the 3′ end of the enhancer also shows some inhibition (4) We note that in the knockout experiments with the lgμ intronic enhancer, inhibition of rearrangement is much more profound when the neomycin gene is left in the locus (5). See also P Artelt et al , Gene 99, 249 (1991), for a possible silencing effect of the neomycin gene
39. R. R. Hardy, C. E. Carmack, S. A. Shinton, J. D. Kemp, K Hayakawa, J. Exp. Med. 173, 1213 (1991).
40. a, V T Oi and L. A. Herzenberg. Mol. Immunol. 16, 1005 (1979)]; R33-18 [anti-κ; R Grutzmann, thesis, University of Cologne, Cologne, Germany (1981)], goat antibody to mouse λ(Southern Biotechnology Association); LS136 [anti-λ1; M. Reth, thesis, University of Cologne, Cologne. Germany (1981)]; S7 (anti-CD43/S7; provided by S Kemp); and BP-1 and 30F1 [anti-HSA (28)].
41. a, V T Oi and L. A. Herzenberg. Mol. Immunol. 16, 1005 (1979)]; R33-18 [anti-κ; R Grutzmann, thesis, University of Cologne, Cologne, Germany (1981)], goat antibody to mouse λ(Southern Biotechnology Association); LS136 [anti-λ1; M. Reth, thesis, University of Cologne, Cologne. Germany (1981)]; S7 (anti-CD43/S7; provided by S Kemp); and BP-1 and 30F1 [anti-HSA (28)].
42. a, V T Oi and L. A. Herzenberg. Mol. Immunol. 16, 1005 (1979)]; R33-18 [anti-κ; R Grutzmann, thesis, University of Cologne, Cologne, Germany (1981)], goat antibody to mouse λ(Southern Biotechnology Association); LS136 [anti-λ1; M. Reth, thesis, University of Cologne, Cologne. Germany (1981)]; S7 (anti-CD43/S7; provided by S Kemp); and BP-1 and 30F1 [anti-HSA (28)].
43. a, V T Oi and L. A. Herzenberg. Mol. Immunol. 16, 1005 (1979)]; R33-18 [anti-κ; R Grutzmann, thesis, University of Cologne, Cologne, Germany (1981)], goat antibody to mouse λ(Southern Biotechnology Association); LS136 [anti-λ1; M. Reth, thesis, University of Cologne, Cologne. Germany (1981)]; S7 (anti-CD43/S7; provided by S Kemp); and BP-1 and 30F1 [anti-HSA (28)].
44. a, V T Oi and L. A. Herzenberg. Mol. Immunol. 16, 1005 (1979)]; R33-18 [anti-κ; R Grutzmann, thesis, University of Cologne, Cologne, Germany (1981)], goat antibody to mouse λ(Southern Biotechnology Association); LS136 [anti-λ1; M. Reth, thesis, University of Cologne, Cologne. Germany (1981)]; S7 (anti-CD43/S7; provided by S Kemp); and BP-1 and 30F1 [anti-HSA (28)].
45. R Kühn, J. Lohler, D Rennick, K Rajewsky, W Muller, Cell 75, 263 (1993)
46. 2, 200 μM of each deoxynucleotide triphosphate, 25 pmol of each primer, and 1 U of Taq polymerase (Perkin- Elmer)
47. We thank B. Van Ness for providing us the pSPIg8 plasmid; R. Kühn for the E14 1 ES clone; A Egert for advice and technical help; C. Steinberg for helpful comments and critical reading of the manuscript, R. Torres, Y.-R. Zou, F Huetz, and L Quint for encouragements and discussions; J.-P. De Villartay for phosphorimager quantifications; S. Schaal for bone marrow analysis; and C. Garcia for cell sorting experiments. This work was partly supported by a short-term European Molecular Biology Organization fellowship